In vitro activities of telavancin and vancomycin against biofilm-producing Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis strains.
about
Update on the emerging role of telavancin in hospital-acquired infectionsA potential role for daptomycin in enterococcal infections: what is the evidence?Effects of cranberry extracts on growth and biofilm production of Escherichia coli and Staphylococcus species.Infection of orthopedic implants with emphasis on bacterial adhesion process and techniques used in studying bacterial-material interactions.Telavancin in the treatment of Staphylococcus aureus hospital-acquired and ventilator-associated pneumonia: clinical evidence and experience.Ethanol and Isopropyl Alcohol Exposure Increases Biofilm Formation in Staphylococcus aureus and Staphylococcus epidermidis.Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.Streptokinase Treatment Reverses Biofilm-Associated Antibiotic Resistance in Staphylococcus aureusTargeting bacterial membrane function: an underexploited mechanism for treating persistent infectionsA combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms.Impact of bacterial biofilm on the treatment of prosthetic joint infections.Efficacy of telavancin, a lipoglycopeptide antibiotic, in experimental models of Gram-positive infection.Implications and emerging control strategies for ventilator-associated infections.A review of telavancin activity in in vitro biofilms and animal models of biofilm-associated infections.Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review.Pharmacodynamics, pharmacokinetics and clinical efficacy of telavancin in the treatment of pneumonia.Synergistic activity between an antimicrobial polyacrylamide and daptomycin versus Staphylococcus aureus biofilm.New in vitro and in vivo models to evaluate antibiotic efficacy in Staphylococcus aureus prosthetic vascular graft infection.In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms.Telavancin Activity against gram-positive bacteria isolated from patients with skin and skin-structure infections.Clinical and Genetic Risk Factors for Biofilm-Forming Staphylococcus aureus.Identification of Anti-staphylococcal and Anti-biofilm Compounds by Repurposing the Medicines for Malaria Venture Pathogen Box
P2860
Q28083522-60E105CC-166C-4E46-A75E-E22E46CACB7DQ33845776-D778594D-6EEF-4CF0-AA82-2C844E19846BQ34251044-90BF0B6E-D6D0-4B91-BC61-2922C7BD95B9Q34649528-F880F2E2-4B46-463E-9704-0C4A059214BBQ34677611-6C105359-B2A3-4789-9C0F-9F39824F1F7DQ35752751-CE852DEB-BEF2-44F9-AB2C-B7EA39E64E3AQ36060579-09FA2DC3-EE59-4DF4-A509-83AC21187DC2Q36147148-E7ABD48D-11DA-4BDA-B56A-3E031D0E6BAAQ36393640-1D463DB7-3267-4473-AFAD-98C3F680ADE7Q37026608-CBCCE2DB-4D07-4D2C-A268-1CC3033B14B9Q38241057-5961A699-810E-41DE-AE86-AB826BC44767Q38266421-7CB6B12F-3CA9-4438-A548-2E347CDFCB77Q38336386-D0131BCF-DF07-4085-8FA1-0CC9338B9278Q38530316-FEF63380-016A-45C8-948D-1E941A2C7CB0Q38646905-2FEB9771-3736-4933-8004-7071E45D4B9BQ38829519-8527883D-54F6-44C1-8121-C1B169984766Q39787013-5C93914A-820A-4534-9943-212B8987BEC9Q40018152-F9A67410-2A91-484C-B351-AF68F92A8E23Q41184618-DE7936D2-7BC8-4EA9-B0A6-AB462581413CQ42788454-86068EAB-6884-413D-A6D1-BD5BA6C53E10Q52358498-A00C5A90-A24F-4466-A7ED-BB3791FE15BCQ58572061-92922259-F617-407C-9238-EA9CB0747CE6
P2860
In vitro activities of telavancin and vancomycin against biofilm-producing Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis strains.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
In vitro activities of telavan ...... Enterococcus faecalis strains.
@en
type
label
In vitro activities of telavan ...... Enterococcus faecalis strains.
@en
prefLabel
In vitro activities of telavan ...... Enterococcus faecalis strains.
@en
P2860
P356
P1476
In vitro activities of telavan ...... Enterococcus faecalis strains.
@en
P2093
Kerry L LaPlante
Leonard A Mermel
P2860
P304
P356
10.1128/AAC.01642-08
P407
P577
2009-05-18T00:00:00Z